UBS Group’s Bioventus BVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $583K | Sell |
|
|||||
|
2025
Q4 | $608K | Buy |
|
|||||
|
2025
Q3 | $481K | Sell |
|
|||||
|
2025
Q2 | $580K | Buy |
|
|||||
|
2025
Q1 | $422K | Buy |
|
|||||
|
2024
Q4 | $404K | Buy |
|
|||||
|
2024
Q3 | $411K | Buy |
|
|||||
|
2024
Q2 | $73.5K | Buy |
|
|||||
|
2024
Q1 | $6.79K | Sell |
|
|||||
|
2023
Q4 | $12.5K | Sell |
|
|||||
|
2023
Q3 | $14.1K | Buy |
|
|||||
|
2023
Q2 | $5.23K | Sell |
|
|||||
|
2023
Q1 | $16.8K | Buy |
|
|||||
|
2022
Q4 | $33.3K | Buy |
|
|||||
|
2022
Q3 | $51K | Buy |
|
|||||
|
2022
Q2 | $27K | Sell |
|
|||||
|
2022
Q1 | $72K | Sell |
|
|||||
|
2021
Q4 | $197K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $31K | Sell |
|
|||||
|
2021
Q1 | $66K | Buy |
|